Preferred Name |
Cyclophosphamide Anhydrous |
|
Synonyms |
|
|
Definitions |
The anhydrous form of cyclophosphamide, a synthetic nitrogen mustard alkylating agent, with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to active metabolites including phosphoramide mustard, which binds to and crosslinks DNA and RNA, thereby inhibiting DNA replication and protein synthesis. This agent, at low doses, is also a potent immunosuppressant primarily by depleting T-regulatory cells. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61694 |
|
CAS_Registry |
50-18-0 |
|
CHEBI_ID |
CHEBI:4027 |
|
Chemical_Formula |
C7H15Cl2N2O2P |
|
code |
C61694 |
|
Contributing_Source |
FDA |
|
definition |
The anhydrous form of cyclophosphamide, a synthetic nitrogen mustard alkylating agent, with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to active metabolites including phosphoramide mustard, which binds to and crosslinks DNA and RNA, thereby inhibiting DNA replication and protein synthesis. This agent, at low doses, is also a potent immunosuppressant primarily by depleting T-regulatory cells. |
|
FDA_UNII_Code |
6UXW23996M |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C128784 |
|
Is_Value_For_GDC_Property | ||
label |
Cyclophosphamide Anhydrous |
|
Legacy Concept Name |
Cyclophosphamide_Anhydrous |
|
Maps_To |
Cyclophosphamide Anhydrous |
|
Preferred_Name |
Cyclophosphamide Anhydrous |
|
prefixIRI |
NCIT:C61694 |
|
prefLabel |
Cyclophosphamide Anhydrous |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1880207 |
|
subClassOf |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/RXNORM/1545988 | RXNORM | LOOM | |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61694 | NCIT | LOOM | |
http://purl.bioontology.org/ontology/SNOMEDCT/1268997008 | SNOMEDCT | LOOM |